Transmucosal delivery systems for calcitonin: a review (Q33918818)

30 July 2017

1 reference

title

Transmucosal delivery systems for calcitonin: a review (English)

1 reference

30 July 2017

2

Peppas NA

1 reference

30 July 2017

Torres-Lugo M

1

1 reference

30 July 2017

publication date

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

21

1 reference

30 July 2017

issue

12

1 reference

30 July 2017

page(s)

1191-1196

1 reference

Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Improving protein therapeutics with sustained-release formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein. Calcitonine and human growth hormone in comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Degradation pathways of salmon calcitonin in aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Chemistry of the calcitonins

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

A new route of drug administration: intrauterine delivery of insulin and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Adsorption of salmon calcitonin to PLGA microspheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Labelling peptides with fluorescent probes for incorporation into degradable polymers

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Effects of polyacrylic polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Temperature and pH-sensitive polymers for human calcitonin delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Molecular Design and in Vitro Studies of Novel pH-Sensitive Hydrogels for the Oral Delivery of Calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

Peptide hormones: Review of current and emerging uses by nasal delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2800%2900011-9

7 January 2021

10.1016/S0142-9612(00)00011-9

Identifiers

DOI

1 reference

30 July 2017

1 reference